var data={"title":"General anesthesia: Induction","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"topicTitle\">General anesthesia: Induction</div><dl id=\"topicContributors\"><dt><span> </span>Authors:</dt><dd><a href=\"https://www.uptodate.com/contents/general-anesthesia-induction/contributors\" class=\"contributor contributor_credentials\">Adam King, MD</a></dd><dd><a href=\"https://www.uptodate.com/contents/general-anesthesia-induction/contributors\" class=\"contributor contributor_credentials\">Liza M Weavind, MBBCh, FCCM, MMHC</a></dd><dt><span> </span>Section Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/general-anesthesia-induction/contributors\" class=\"contributor contributor_credentials\">Girish P Joshi, MB, BS, MD, FFARCSI</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/general-anesthesia-induction/contributors\" class=\"contributor contributor_credentials\">Nancy A Nussmeier, MD, FAHA</a></dd></dl><p class=\"disclosureLink\"><a href=\"https://www.uptodate.com/contents/general-anesthesia-induction/contributor-disclosure\" class=\"contributor contributor_credentials\">Contributor Disclosures</a></p><div id=\"reviewProcess\"><span>All topics are updated as new evidence becomes available and our <a href=\"https://www.uptodate.com/home/editorial-policy\" target=\"_blank\" class=\"policy policy_editorialpolicy\">peer review process</a> is complete.</span></div><div id=\"literatureReviewDate\"><span class=\"emphasis\">Literature review current through:</span>&#160;Feb 2018.&#160;&#124;&#160;<span class=\"emphasis\">This topic last updated:</span>&#160;Sep 07, 2017.</div><div id=\"topicWhatsNewContainer\"></div><div id=\"topicText\"><p class=\"headingAnchor\" id=\"H2326701429\"><span class=\"h1\">INTRODUCTION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>General anesthesia establishes a reversible state that includes:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Hypnosis</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Amnesia</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Analgesia</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Akinesia</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Autonomic and sensory block</p><p/><p>The goals for induction of general anesthesia are to rapidly, safely, and pleasantly produce these four conditions while maintaining hemodynamic stability and ventilation.</p><p>This topic will discuss preinduction preparations and selection of anesthetic induction techniques and agents. The intravenous induction agents, supplemental adjuvant agents, inhalation anesthetic agents, and neuromuscular blocking agents used to induce general anesthesia are reviewed in detail separately:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>(See <a href=\"topic.htm?path=general-anesthesia-intravenous-induction-agents\" class=\"medical medical_review\">&quot;General anesthesia: Intravenous induction agents&quot;</a>.)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>(See <a href=\"topic.htm?path=inhalation-anesthetic-agents-properties-and-delivery\" class=\"medical medical_review\">&quot;Inhalation anesthetic agents: Properties and delivery&quot;</a>.)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>(See <a href=\"topic.htm?path=clinical-use-of-neuromuscular-blocking-agents-in-anesthesia\" class=\"medical medical_review\">&quot;Clinical use of neuromuscular blocking agents in anesthesia&quot;</a>.)</p><p/><p>Considerations for preoperative evaluation and preparation of the patient are reviewed separately:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>(See <a href=\"topic.htm?path=preoperative-fasting-guidelines\" class=\"medical medical_review\">&quot;Preoperative fasting guidelines&quot;</a>.)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>(See <a href=\"topic.htm?path=preoperative-medical-evaluation-of-the-adult-healthy-patient\" class=\"medical medical_review\">&quot;Preoperative medical evaluation of the adult healthy patient&quot;</a>.)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>(See <a href=\"topic.htm?path=perioperative-medication-management\" class=\"medical medical_review\">&quot;Perioperative medication management&quot;</a>.)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>(See <a href=\"topic.htm?path=evaluation-of-cardiac-risk-prior-to-noncardiac-surgery\" class=\"medical medical_review\">&quot;Evaluation of cardiac risk prior to noncardiac surgery&quot;</a>.)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>(See <a href=\"topic.htm?path=evaluation-of-preoperative-pulmonary-risk\" class=\"medical medical_review\">&quot;Evaluation of preoperative pulmonary risk&quot;</a>.)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>(See <a href=\"topic.htm?path=preanesthesia-evaluation-for-noncardiac-surgery\" class=\"medical medical_review\">&quot;Preanesthesia evaluation for noncardiac surgery&quot;</a>.)</p><p/><p class=\"headingAnchor\" id=\"H2107374177\"><span class=\"h1\">CONTINUUM OF SEDATION DURING ANESTHETIC INDUCTION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Anesthetic agents demonstrate a dose-response effect, with progressively higher doses providing progressively deeper levels of sedation and anesthesia (<a href=\"image.htm?imageKey=ANEST%2F107796\" class=\"graphic graphic_table graphicRef107796 \">table 1</a>).</p><p>Notably, sedation progresses to general anesthesia as a continuum of effect rather than as a consecutive series of distinct states with clear transitions. <span class=\"nowrap\">Light/minimal</span> sedation with anxiolysis and analgesia is the lightest plane, in which responsiveness to voice, airway patency, spontaneous ventilation, and cardiovascular function are preserved. Moderate sedation, also termed conscious sedation, represents a deeper level of sedation and analgesia, in which the patient remains responsive to voice and has intact airway patency and spontaneous ventilation, although blood pressure may be reduced. Deep sedation is a state in which the patient is no longer responsive to voice; airway patency, spontaneous ventilation, and cardiovascular function may also be compromised. However, the patient still moves in response to a noxious surgical stimulus.</p><p>General anesthesia represents an anesthetic depth at which the patient will not respond to voice or to noxious surgical stimuli (stage III) (<a href=\"image.htm?imageKey=ANEST%2F107796\" class=\"graphic graphic_table graphicRef107796 \">table 1</a>). As the patient progresses from Stage I to stage III surgical anesthesia, airway reflexes and patency, spontaneous ventilation, cardiovascular function, and muscle tone become increasingly depressed. Stage IV anesthetic depth is &ldquo;too deep&rdquo; with profound medullary depression that includes the cardiovascular and respiratory centers and eventually leads to the need for cardiopulmonary resuscitation (<a href=\"image.htm?imageKey=ANEST%2F107796\" class=\"graphic graphic_table graphicRef107796 \">table 1</a>). Notably, patients may rapidly transition from one stage of anesthetic depth to the next, so that urgent interventions to support the airway and respiratory and cardiovascular function may become necessary. </p><p class=\"headingAnchor\" id=\"H254392428\"><span class=\"h1\">PREPARATION FOR ANESTHETIC INDUCTION</span></p><p class=\"headingAnchor\" id=\"H1788937456\"><span class=\"h2\">Preparation before patient arrival</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The following steps are undertaken before the patient arrives:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Anesthesia machine checkout</strong> &ndash; The anesthesia machine checkout should be performed prior to the patient's arrival in the operating room (<a href=\"image.htm?imageKey=ANEST%2F101563\" class=\"graphic graphic_table graphicRef101563 \">table 2</a>) [<a href=\"https://www.uptodate.com/contents/general-anesthesia-induction/abstract/1\" class=\"abstract_t\">1</a>]. (See <a href=\"topic.htm?path=anesthesia-machines-prevention-diagnosis-and-management-of-malfunctions\" class=\"medical medical_review\">&quot;Anesthesia machines: Prevention, diagnosis, and management of malfunctions&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Airway equipment preparation</strong> &ndash; Since all anesthetic induction agents and adjuvants may cause respiratory depression, preparations for advanced airway management are necessary. (See <a href=\"topic.htm?path=airway-management-for-induction-of-general-anesthesia#H10737465\" class=\"medical medical_review\">&quot;Airway management for induction of general anesthesia&quot;, section on 'Preparation for induction of anesthesia'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Drug preparation</strong> &ndash; Routinely administered anesthetic drugs should be prepared. Drugs for treatment of common complications and emergencies should be immediately available. (See <a href=\"topic.htm?path=preanesthesia-evaluation-for-noncardiac-surgery\" class=\"medical medical_review\">&quot;Preanesthesia evaluation for noncardiac surgery&quot;</a>.)</p><p/><p class=\"headingAnchor\" id=\"H2417514694\"><span class=\"h2\">Preparation after patient arrival</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>After patient arrival, the following should be completed:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Monitoring</strong> &ndash; Prior to induction of general anesthesia, the patient should be connected to standard American Society of Anesthesiologists (ASA) monitors [<a href=\"https://www.uptodate.com/contents/general-anesthesia-induction/abstract/2\" class=\"abstract_t\">2</a>]. Preinduction measurements are obtained to ensure proper functioning of the monitors and to establish the patient's baseline values.</p><p/><p class=\"bulletIndent1\">Standard monitors include but are not limited to: electrocardiogram (ECG), pulse oximetry, blood pressure (BP), and temperature monitors, as well as an oxygen (O<sub>2</sub>) analyzer and a continuous end-tidal carbon dioxide (ETCO<sub>2</sub>) analyzer (eg, capnography, capnometry, or mass spectroscopy) in the patient breathing system (<a href=\"image.htm?imageKey=ANEST%2F110080\" class=\"graphic graphic_table graphicRef110080 \">table 3</a>). (See <a href=\"topic.htm?path=monitoring-during-anesthesia\" class=\"medical medical_review\">&quot;Monitoring during anesthesia&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Intravenous access</strong> &ndash; Virtually all adult patients have at least one peripheral venous or other vascular access catheter placed prior to induction. Catheters should be checked to ensure that they are patent. Intravenous (IV) fluids and equipment to obtain additional venous access should be immediately available. (See <a href=\"topic.htm?path=peripheral-venous-access-in-adults\" class=\"medical medical_review\">&quot;Peripheral venous access in adults&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Preprocedure checklist</strong> &ndash; An appropriate preprocedure checklist should be completed; an example is provided in the table (<a href=\"image.htm?imageKey=ANEST%2F52392\" class=\"graphic graphic_table graphicRef52392 \">table 4</a>).</p><p/><p class=\"headingAnchor\" id=\"H2134519527\"><span class=\"h2\">Preparation immediately before induction</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Positioning for induction </strong>&ndash; Before induction of anesthesia, the patient's head should be placed in the sniffing position (atlanto-occipital extension with head elevation of 3 to 7 cm [<a href=\"https://www.uptodate.com/contents/general-anesthesia-induction/abstract/3\" class=\"abstract_t\">3</a>]), supported so that the neck is flexed and the head extended (assuming an absence of cervical spine pathology). If not contraindicated, the head of the bed is elevated 20 to 30 degrees.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Preoxygenation (denitrogenation</strong>) &ndash; Prior to administration of any anesthetic induction agents, the patient is preoxygenated (denitrogenated) with 100 percent O<sub>2</sub> to increase O<sub>2</sub> reserve, thereby providing additional time to secure the airway [<a href=\"https://www.uptodate.com/contents/general-anesthesia-induction/abstract/4,5\" class=\"abstract_t\">4,5</a>]. (See <a href=\"topic.htm?path=airway-management-for-induction-of-general-anesthesia#H10737491\" class=\"medical medical_review\">&quot;Airway management for induction of general anesthesia&quot;, section on 'Preoxygenation'</a>.)</p><p/><p class=\"headingAnchor\" id=\"H295889468\"><span class=\"h1\">SELECTION OF INDUCTION TECHNIQUE</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Induction of general anesthesia may be accomplished by employing a technique with either primarily intravenous (IV) or primarily inhalation agents.</p><p>The ideal induction agent has a rapid onset of action, minimal cardiopulmonary or other side effects, and is cleared from the bloodstream quickly so that recovery is rapid. None of the available induction agents is ideal for all patients, and all have side effects. Age and coexisting diseases affect selection of anesthetic induction and adjuvant agents, as well as estimation of safe and effective doses of each agent.</p><p>In order to minimize the total dose of any one anesthetic agent and thereby reduce the incidence of drug-related side effects, we typically administer multiple agents to accomplish anesthetic induction, including one or more adjuvant agents, and a neuromuscular blocking agent (NMBA) if endotracheal intubation is planned. Various combinations of drugs are effective, and either IV or inhalation routes of administration, or both, may be employed.</p><p>Inhalation agents are also frequently employed as a component of anesthetic induction, after initial loss of consciousness has been achieved with IV agents. All inhalation agents deepen anesthesia so that airway reflexes and sympathetic stress responses are blunted during laryngoscopy. The potent volatile agents also induce a dose-dependent decrease in skeletal muscle tone, which improves conditions for insertion of an endotracheal tube (ETT) or a supraglottic airway (SGA). (See <a href=\"topic.htm?path=inhalation-anesthetic-agents-clinical-effects-and-uses#H4241879134\" class=\"medical medical_review\">&quot;Inhalation anesthetic agents: Clinical effects and uses&quot;, section on 'Use as a supplement (all inhalation agents)'</a>.)</p><p class=\"headingAnchor\" id=\"H295889145\"><span class=\"h1\">INTRAVENOUS ANESTHETIC INDUCTION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Adult patients usually have intravenous (IV) access and prefer induction with IV agents. The commonly used IV sedative-hypnotic induction agents and adjuvant IV agents (eg, an opioid, <a href=\"topic.htm?path=lidocaine-drug-information\" class=\"drug drug_general\">lidocaine</a>, <span class=\"nowrap\">and/or</span> a benzodiazepine [usually <a href=\"topic.htm?path=midazolam-drug-information\" class=\"drug drug_general\">midazolam</a>]) used to supplement anesthetic effects of the sedative-hypnotic induction agents are reviewed in detail separately (<a href=\"image.htm?imageKey=ANEST%2F102350\" class=\"graphic graphic_table graphicRef102350 \">table 5</a> and <a href=\"image.htm?imageKey=ANEST%2F106541\" class=\"graphic graphic_table graphicRef106541 \">table 6</a>). (See <a href=\"topic.htm?path=general-anesthesia-intravenous-induction-agents\" class=\"medical medical_review\">&quot;General anesthesia: Intravenous induction agents&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H3372096285\"><span class=\"h2\">Induction with endotracheal intubation</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>During induction with planned laryngoscopy and endotracheal tube insertion, one or more adjuvant IV agents are typically administered to supplement the anesthetic effects of the selected sedative-hypnotic induction agent (<a href=\"image.htm?imageKey=ANEST%2F106541\" class=\"graphic graphic_table graphicRef106541 \">table 6</a>).</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Typically, an opioid (eg, <a href=\"topic.htm?path=fentanyl-drug-information\" class=\"drug drug_general\">fentanyl</a> 25 to 100 mcg [ie, 0.5 to 1 <span class=\"nowrap\">mcg/kg])</span> is administered three to five minutes before the sedative-hypnotic agent (eg, <a href=\"topic.htm?path=propofol-drug-information\" class=\"drug drug_general\">propofol</a> 1 to 2.5 <span class=\"nowrap\">mg/kg)</span> to achieve an optimal synergistic effect [<a href=\"https://www.uptodate.com/contents/general-anesthesia-induction/abstract/6\" class=\"abstract_t\">6</a>]. For example, fentanyl can reduce the induction dose requirement of propofol by 40 to 70 percent [<a href=\"https://www.uptodate.com/contents/general-anesthesia-induction/abstract/6-10\" class=\"abstract_t\">6-10</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>In some cases, <a href=\"topic.htm?path=midazolam-drug-information\" class=\"drug drug_general\">midazolam</a> may be administered in the immediate preoperative period or as part of the induction sequence for its amnestic and anxiolytic effects; midazolam also supplements sedation and reduces dose requirement for the selected sedative-hypnotic induction agent [<a href=\"https://www.uptodate.com/contents/general-anesthesia-induction/abstract/8\" class=\"abstract_t\">8</a>]. However, routine use of pre-induction midazolam should be avoided as the risks of administration outweigh the benefits [<a href=\"https://www.uptodate.com/contents/general-anesthesia-induction/abstract/11,12\" class=\"abstract_t\">11,12</a>]. </p><p/><p>While <a href=\"topic.htm?path=fentanyl-drug-information\" class=\"drug drug_general\">fentanyl</a> and <a href=\"topic.htm?path=midazolam-drug-information\" class=\"drug drug_general\">midazolam</a> should be administered a few minutes before induction, all other agents are typically administered in rapid succession over a period of 60 to 120 seconds:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"topic.htm?path=lidocaine-drug-information\" class=\"drug drug_general\">Lidocaine</a> 0.5 to 1.5 <span class=\"nowrap\">mg/kg</span> may also be administered to blunt the airway responses to laryngoscopy and endotracheal intubation and supplement the anesthetic effects of the induction agent [<a href=\"https://www.uptodate.com/contents/general-anesthesia-induction/abstract/13-26\" class=\"abstract_t\">13-26</a>]. A lower dose of lidocaine 20 to 30 mg is often administered prior to injection of <a href=\"topic.htm?path=propofol-drug-information\" class=\"drug drug_general\">propofol</a> and other induction agents to reduce pain caused by their injection [<a href=\"https://www.uptodate.com/contents/general-anesthesia-induction/abstract/27-32\" class=\"abstract_t\">27-32</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>An NMBA may be administered to facilitate endotracheal intubation. Endotracheal intubation may be accomplished shortly after administration of the NMBA (approximately 60 seconds after <a href=\"topic.htm?path=succinylcholine-suxamethonium-drug-information\" class=\"drug drug_general\">succinylcholine</a> or 120 seconds after a nondepolarizing NMBA) (<a href=\"image.htm?imageKey=ANEST%2F114271\" class=\"graphic graphic_table graphicRef114271 \">table 7</a>). (See <a href=\"#H2800567302\" class=\"local\">'Neuromuscular blocking agents'</a> below.)</p><p/><p class=\"headingAnchor\" id=\"H1691645889\"><span class=\"h2\">Induction with supraglottic airway placement</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>During IV induction with planned insertion of a supraglottic airway (SGA) such as a laryngeal mask airway (LMA), adequate depth of anesthesia must be achieved to avoid coughing, gagging, breath-holding, laryngospasm, or bronchospasm. (See <a href=\"topic.htm?path=supraglottic-devices-including-laryngeal-mask-airways-for-airway-management-for-anesthesia-in-adults#H519470980\" class=\"medical medical_review\">&quot;Supraglottic devices (including laryngeal mask airways) for airway management for anesthesia in adults&quot;, section on 'Placement technique'</a>.)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"topic.htm?path=lidocaine-drug-information\" class=\"drug drug_general\">Lidocaine</a> is typically administered prior to the sedative hypnotic agent, similar to induction with planned endotracheal intubation. (See <a href=\"#H3372096285\" class=\"local\">'Induction with endotracheal intubation'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Opioid administration during the induction sequence may be minimized or avoided to allow spontaneous ventilation immediately after induction and avoid a period of postinduction apnea. (See <a href=\"topic.htm?path=supraglottic-devices-including-laryngeal-mask-airways-for-airway-management-for-anesthesia-in-adults#H697568266\" class=\"medical medical_review\">&quot;Supraglottic devices (including laryngeal mask airways) for airway management for anesthesia in adults&quot;, section on 'Choice of mode of ventilation'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>If difficulty with SGA placement or initial ventilation is encountered, an additional sedative-hypnotic agent is typically administered. (See <a href=\"topic.htm?path=supraglottic-devices-including-laryngeal-mask-airways-for-airway-management-for-anesthesia-in-adults#H519470986\" class=\"medical medical_review\">&quot;Supraglottic devices (including laryngeal mask airways) for airway management for anesthesia in adults&quot;, section on 'Troubleshooting'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Occasionally, a small dose of an NMBA is employed to facilitate SGA placement and prevent or treat airway responses. (See <a href=\"topic.htm?path=supraglottic-devices-including-laryngeal-mask-airways-for-airway-management-for-anesthesia-in-adults#H692856351\" class=\"medical medical_review\">&quot;Supraglottic devices (including laryngeal mask airways) for airway management for anesthesia in adults&quot;, section on 'Use of neuromuscular blocking agents'</a>.)</p><p/><p class=\"headingAnchor\" id=\"H295889239\"><span class=\"h1\">INHALATION ANESTHETIC INDUCTION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>An inhalation induction is often selected for the following types of patients: </p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Pediatric patients</strong> &ndash; Primary induction with inhaled agents is usually preferred by pediatric patients because of their fear of needles and response to the pain of a needle stick [<a href=\"https://www.uptodate.com/contents/general-anesthesia-induction/abstract/33\" class=\"abstract_t\">33</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Adult patients</strong> &ndash; Inhalation induction may be preferred if spontaneous breathing during induction is desired (eg, tracheal stenosis or intraoral, pharyngeal, or mediastinal mass causing compression of the airway) or when IV access cannot be obtained. Adult patient satisfaction may be lower with a primary inhalation induction compared with IV induction due to the unpleasant odor of the gas [<a href=\"https://www.uptodate.com/contents/general-anesthesia-induction/abstract/34\" class=\"abstract_t\">34</a>] and a higher incidence of postoperative nausea and vomiting (PONV) [<a href=\"https://www.uptodate.com/contents/general-anesthesia-induction/abstract/34-36\" class=\"abstract_t\">34-36</a>]. </p><p/><p>Compared with IV induction, inhalation induction time is longer, usually requiring several minutes of ventilation. Therefore, this technique is not suitable for rapid sequence induction and intubation (RSII). (See <a href=\"topic.htm?path=rapid-sequence-induction-and-intubation-rsii-for-anesthesia\" class=\"medical medical_review\">&quot;Rapid sequence induction and intubation (RSII) for anesthesia&quot;</a>.)</p><p>Inhalation induction of anesthesia requires a high concentration of a volatile anesthetic agent, with or without <a href=\"topic.htm?path=nitrous-oxide-drug-information\" class=\"drug drug_general\">nitrous oxide</a> (N<sub>2</sub>O). Development of non-pungent, nonirritant volatile anesthetics that have rapid onset, particularly <a href=\"topic.htm?path=sevoflurane-drug-information\" class=\"drug drug_general\">sevoflurane</a>, has made inhalation induction of anesthesia via facemask a more pleasant and viable option compared with older inhalation agents [<a href=\"https://www.uptodate.com/contents/general-anesthesia-induction/abstract/35\" class=\"abstract_t\">35</a>]. Properties, mechanisms of action, and delivery of inhalation agents are discussed separately (<a href=\"image.htm?imageKey=ANEST%2F113972\" class=\"graphic graphic_table graphicRef113972 \">table 8</a>). (See <a href=\"topic.htm?path=inhalation-anesthetic-agents-properties-and-delivery#H1913196443\" class=\"medical medical_review\">&quot;Inhalation anesthetic agents: Properties and delivery&quot;, section on 'Factors affecting inhalation anesthetic delivery'</a>.) </p><p>Modified administration techniques can be used to facilitate the speed of anesthetic induction. For example, the breathing circuit may be primed with a high <a href=\"topic.htm?path=sevoflurane-drug-information\" class=\"drug drug_general\">sevoflurane</a> concentration (eg, 8 percent) plus N<sub>2</sub>O. Then the patient is instructed to take a vital capacity breath (defined as a complete expiration followed by a complete inspiration), followed by a period of apnea with inflated lungs (ie, &quot;breath-holding&quot;) [<a href=\"https://www.uptodate.com/contents/general-anesthesia-induction/abstract/37\" class=\"abstract_t\">37</a>]. Typically this single breath technique achieves the 2 percent alveolar sevoflurane concentration required to tolerate a painful intervention such as a surgical incision [<a href=\"https://www.uptodate.com/contents/general-anesthesia-induction/abstract/38\" class=\"abstract_t\">38</a>]. (See <a href=\"topic.htm?path=inhalation-anesthetic-agents-properties-and-delivery#H1403794274\" class=\"medical medical_review\">&quot;Inhalation anesthetic agents: Properties and delivery&quot;, section on 'Technique-related considerations'</a>.)</p><p class=\"headingAnchor\" id=\"H1232736222\"><span class=\"h2\">Volatile inhalation agents</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Advantages for induction of general anesthesia that are shared by all potent volatile anesthetic agents include excellent bronchodilation, dose-dependent decrease in skeletal muscle tone, and decrease in cerebral metabolic rate of oxygen consumption (CMRO<sub>2</sub>). Disadvantages of all volatile agents include respiratory depression, systemic vasodilation, and decreased blood pressure (BP); these are also dose-dependent. Also, all potent volatile agents may precipitate malignant hyperthermia. (See <a href=\"topic.htm?path=inhalation-anesthetic-agents-clinical-effects-and-uses#H425000324\" class=\"medical medical_review\">&quot;Inhalation anesthetic agents: Clinical effects and uses&quot;, section on 'Other clinical effects'</a>.) </p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"topic.htm?path=sevoflurane-drug-information\" class=\"drug drug_general\">Sevoflurane</a><strong> </strong>&mdash; Sevoflurane is the most frequently used inhaled agent for induction of anesthesia. Sevoflurane has many characteristics of the ideal induction agent, including relatively rapid onset due to its low tissue and blood solubility, which also result in rapid clearance from the bloodstream and rapid recovery. The time to loss of consciousness may be as little as 60 seconds if a high concentration of sevoflurane (eg, 4 to 8 percent) is briefly delivered via a facemask [<a href=\"https://www.uptodate.com/contents/general-anesthesia-induction/abstract/33,37,39\" class=\"abstract_t\">33,37,39</a>]. It is the most commonly used potent volatile inhaled agent because of its minimal odor, lack of pungency, and potent bronchodilating characteristics [<a href=\"https://www.uptodate.com/contents/general-anesthesia-induction/abstract/33-36,40-42\" class=\"abstract_t\">33-36,40-42</a>]. (See <a href=\"topic.htm?path=inhalation-anesthetic-agents-clinical-effects-and-uses#H670378431\" class=\"medical medical_review\">&quot;Inhalation anesthetic agents: Clinical effects and uses&quot;, section on 'Sevoflurane'</a> and <a href=\"topic.htm?path=inhalation-anesthetic-agents-clinical-effects-and-uses#H918523793\" class=\"medical medical_review\">&quot;Inhalation anesthetic agents: Clinical effects and uses&quot;, section on 'Induction of general anesthesia'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Halothane </strong>&mdash; Halothane is a sweet-smelling gas with only moderate pungency. Halothane is no longer commercially available in North America due to its adverse effects (particularly the possibility of halothane hepatitis), and the development of newer inhalation agents that have replaced it, in particular <a href=\"topic.htm?path=sevoflurane-drug-information\" class=\"drug drug_general\">sevoflurane</a>. Also, halothane has the slowest onset during induction of anesthesia compared with all other potent inhalation agents because of its high tissue and blood solubility. Other disadvantages include significant myocardial depression at higher doses and risk of arrhythmias due to sensitization of the myocardium to catecholamines (either endogenous or exogenously administered <a href=\"topic.htm?path=epinephrine-adrenaline-drug-information\" class=\"drug drug_general\">epinephrine</a> or <a href=\"topic.htm?path=norepinephrine-noradrenaline-drug-information\" class=\"drug drug_general\">norepinephrine</a>). However, halothane is still widely used for both induction and maintenance of general anesthesia in many countries with limited resources due to its low cost and wide availability. (See <a href=\"topic.htm?path=inhalation-anesthetic-agents-clinical-effects-and-uses#H4266242853\" class=\"medical medical_review\">&quot;Inhalation anesthetic agents: Clinical effects and uses&quot;, section on 'Halothane'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"topic.htm?path=desflurane-drug-information\" class=\"drug drug_general\">Desflurane</a><strong> </strong>&mdash; Desflurane is rarely used to induce anesthesia via facemask because it is the most pungent of the volatile anesthetics and has the highest incidence of airway irritation (coughing, salivation, breath-holding, laryngospasm) at high concentrations [<a href=\"https://www.uptodate.com/contents/general-anesthesia-induction/abstract/40,43\" class=\"abstract_t\">40,43</a>]. Also, desflurane can cause sympathetic stimulation, tachycardia, and hypertension when administered in high or abruptly increased inspired concentrations. Since any inhalation agent must be rapidly increased to produce a high concentration during induction of general anesthesia in an awake patient, these properties of desflurane limit its use as an induction agent. (See <a href=\"topic.htm?path=inhalation-anesthetic-agents-clinical-effects-and-uses#H1665285148\" class=\"medical medical_review\">&quot;Inhalation anesthetic agents: Clinical effects and uses&quot;, section on 'Desflurane'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"topic.htm?path=isoflurane-drug-information\" class=\"drug drug_general\">Isoflurane</a><strong> </strong>&mdash;Isoflurane, the most potent of the volatile anesthetics, is not ideal for use as the sole induction agent because it is relatively pungent and has a slow onset (and recovery) compared with <a href=\"topic.htm?path=sevoflurane-drug-information\" class=\"drug drug_general\">sevoflurane</a>. (See <a href=\"topic.htm?path=inhalation-anesthetic-agents-clinical-effects-and-uses#H2453040825\" class=\"medical medical_review\">&quot;Inhalation anesthetic agents: Clinical effects and uses&quot;, section on 'Isoflurane'</a>.)</p><p/><p class=\"headingAnchor\" id=\"H163527534\"><span class=\"h2\">Nitrous oxide gas</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>N<sub>2</sub>O is a sweet-smelling gas without pungency or potential for airway irritation. It is often used as an adjuvant agent during inhalation induction of general anesthesia. N<sub>2</sub>O increases speed of anesthetic onset if coadministered with any potent volatile inhalation agent, compared with administration of the potent agent alone, due to a phenomenon termed the &quot;second gas&quot; effect. (See <a href=\"topic.htm?path=inhalation-anesthetic-agents-properties-and-delivery#H3037530422\" class=\"medical medical_review\">&quot;Inhalation anesthetic agents: Properties and delivery&quot;, section on 'Second gas effect'</a> and <a href=\"topic.htm?path=inhalation-anesthetic-agents-clinical-effects-and-uses#H72857815\" class=\"medical medical_review\">&quot;Inhalation anesthetic agents: Clinical effects and uses&quot;, section on 'Nitrous oxide gas'</a>.)</p><p>N<sub>2</sub>O is avoided during induction in patients with possible pre-existing bowel distention, increased middle ear pressure, pneumothorax, pneumoperitoneum, pneumocephalus, intraocular gas, or venous air embolism [<a href=\"https://www.uptodate.com/contents/general-anesthesia-induction/abstract/44-46\" class=\"abstract_t\">44-46</a>]. Further gaseous distension of such spaces has potentially significant adverse consequences (eg, nausea with emesis, tension pneumothorax, increased intracranial pressure, vision loss, expansion of entrapped intravascular air). Also, N<sub>2</sub>O is typically avoided during induction in patients with cardiomyopathy and pulmonary hypertension because it causes mild myocardial depression and sympathetic nervous system stimulation with increases in pulmonary vascular resistance. (See <a href=\"topic.htm?path=inhalation-anesthetic-agents-clinical-effects-and-uses#H1206995058\" class=\"medical medical_review\">&quot;Inhalation anesthetic agents: Clinical effects and uses&quot;, section on 'Disadvantages and adverse effects'</a>.)</p><p class=\"headingAnchor\" id=\"H2800567302\"><span class=\"h1\">NEUROMUSCULAR BLOCKING AGENTS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>During induction of general anesthesia, a neuromuscular blocking agent (NMBA) is usually administered to facilitate laryngoscopy if endotracheal intubation is planned, as discussed separately (<a href=\"image.htm?imageKey=ANEST%2F114271\" class=\"graphic graphic_table graphicRef114271 \">table 7</a>). (See <a href=\"topic.htm?path=clinical-use-of-neuromuscular-blocking-agents-in-anesthesia#H2476711246\" class=\"medical medical_review\">&quot;Clinical use of neuromuscular blocking agents in anesthesia&quot;, section on 'Endotracheal intubation'</a>.)</p><p>Because of its rapid onset of action, we select SCh in patients requiring rapid sequence induction and intubation (RSII) and in those with a potentially difficult airway (when the decision has been made to use an NMBA), unless SCh is specifically contraindicated. (See <a href=\"topic.htm?path=clinical-use-of-neuromuscular-blocking-agents-in-anesthesia#H370576226\" class=\"medical medical_review\">&quot;Clinical use of neuromuscular blocking agents in anesthesia&quot;, section on 'Succinylcholine'</a>.)</p><p>Nondepolarizing NMBAs (eg, <a href=\"topic.htm?path=rocuronium-drug-information\" class=\"drug drug_general\">rocuronium</a>, <a href=\"topic.htm?path=vecuronium-drug-information\" class=\"drug drug_general\">vecuronium</a>, <a href=\"topic.htm?path=cisatracurium-drug-information\" class=\"drug drug_general\">cisatracurium</a>, <a href=\"topic.htm?path=atracurium-drug-information\" class=\"drug drug_general\">atracurium</a>, and <a href=\"topic.htm?path=pancuronium-drug-information\" class=\"drug drug_general\">pancuronium</a>) have a slower onset than SCh but are often selected for intubation to avoid the side effects of SCh if the patient does not need RSII and does not have a potentially difficult airway (<a href=\"image.htm?imageKey=ANEST%2F114271\" class=\"graphic graphic_table graphicRef114271 \">table 7</a>). If a relatively large dose of rocuronium is used to achieve swift onset of excellent intubating conditions, the neuromuscular blocking effect may be terminated relatively rapidly by administering <a href=\"topic.htm?path=sugammadex-drug-information\" class=\"drug drug_general\">sugammadex</a> 16 <span class=\"nowrap\">mg/kg</span> if necessary (eg, inability to intubate or ventilate) [<a href=\"https://www.uptodate.com/contents/general-anesthesia-induction/abstract/47,48\" class=\"abstract_t\">47,48</a>]. (See <a href=\"topic.htm?path=clinical-use-of-neuromuscular-blocking-agents-in-anesthesia#H3507460328\" class=\"medical medical_review\">&quot;Clinical use of neuromuscular blocking agents in anesthesia&quot;, section on 'Nondepolarizing neuromuscular blocking agents'</a>.)</p><p>Occasionally, a small dose of an NMBA is employed to facilitate supraglottic airway (SGA) placement and prevent coughing and other airway responses. (See <a href=\"#H1691645889\" class=\"local\">'Induction with supraglottic airway placement'</a> above.)</p><p class=\"headingAnchor\" id=\"H2986651352\"><span class=\"h1\">VASOPRESSOR AGENTS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Vasopressor agents are administered, if necessary, to treat hypotension during induction of general anesthesia.</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"topic.htm?path=phenylephrine-drug-information\" class=\"drug drug_general\">Phenylephrine</a> &ndash; Phenylephrine is a pure alpha<sub>1</sub>-adrenergic agonist that causes both arterial and venous vasoconstriction. Administration of phenylephrine 40 to 100 mcg increases blood pressure (BP); doses may be repeated if necessary.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"topic.htm?path=ephedrine-systemic-drug-information\" class=\"drug drug_general\">Ephedrine</a> &ndash; Ephedrine is an alpha and beta receptor adrenergic agonist that causes release of endogenous <a href=\"topic.htm?path=norepinephrine-noradrenaline-drug-information\" class=\"drug drug_general\">norepinephrine</a> stores. Administration of ephedrine 5 to 10 mg increases both BP and heart rate (HR); doses may be repeated if necessary.</p><p/><p>Occasionally an infusion of a vasopressor agent (eg, <a href=\"topic.htm?path=phenylephrine-drug-information\" class=\"drug drug_general\">phenylephrine</a>) is necessary during and immediately after administration of induction agents (<a href=\"image.htm?imageKey=ANEST%2F96387\" class=\"graphic graphic_table graphicRef96387 \">table 9</a>). </p><p class=\"headingAnchor\" id=\"H3152925089\"><span class=\"h1\">PATIENT-SPECIFIC AND PROCEDURE-SPECIFIC CONSIDERATIONS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Coexisting diseases, conditions, and the planned surgical procedure may affect selection of anesthetic techniques and specific induction and adjuvant agents. These are discussed in separate topic reviews related to the condition <span class=\"nowrap\">and/or</span> surgical procedure. As examples:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Hemodynamic instability </strong>&ndash; We typically select <a href=\"topic.htm?path=etomidate-drug-information\" class=\"drug drug_general\">etomidate</a> or <a href=\"topic.htm?path=ketamine-drug-information\" class=\"drug drug_general\">ketamine</a> to induce general anesthesia in patients with actual or potential hemodynamic instability due to hypovolemia, vasodilation, or severe myocardial dysfunction. (See <a href=\"topic.htm?path=general-anesthesia-intravenous-induction-agents\" class=\"medical medical_review\">&quot;General anesthesia: Intravenous induction agents&quot;</a> and <a href=\"topic.htm?path=intraoperative-management-of-shock-in-adults\" class=\"medical medical_review\">&quot;Intraoperative management of shock in adults&quot;</a>.)</p><p/><p class=\"bulletIndent1\">Administration of a vasopressor (eg, <a href=\"topic.htm?path=phenylephrine-drug-information\" class=\"drug drug_general\">phenylephrine</a> <span class=\"nowrap\">and/or</span> <a href=\"topic.htm?path=ephedrine-systemic-drug-information\" class=\"drug drug_general\">ephedrine</a>) may be necessary to prevent or treat hypotension. (See <a href=\"#H2986651352\" class=\"local\">'Vasopressor agents'</a> above.)</p><p/><p class=\"bulletIndent1\">Adjuvant agents (eg, opioids, <a href=\"topic.htm?path=lidocaine-drug-information\" class=\"drug drug_general\">lidocaine</a>, <a href=\"topic.htm?path=midazolam-drug-information\" class=\"drug drug_general\">midazolam</a>) are usually eliminated, or at least reduced, in these patients. (See <a href=\"topic.htm?path=general-anesthesia-intravenous-induction-agents#H2272654275\" class=\"medical medical_review\">&quot;General anesthesia: Intravenous induction agents&quot;, section on 'Adjuvant agents'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Older adults </strong>&ndash; The doses of intravenous and inhalation induction agents should be reduced in older patients. (See <a href=\"topic.htm?path=anesthesia-for-the-older-adult#H183400993\" class=\"medical medical_review\">&quot;Anesthesia for the older adult&quot;, section on 'Sedative-hypnotics'</a> and <a href=\"topic.htm?path=anesthesia-for-the-older-adult#H183400999\" class=\"medical medical_review\">&quot;Anesthesia for the older adult&quot;, section on 'Inhalation anesthetics'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Brain tumor or head injury</strong> &ndash; (See <a href=\"topic.htm?path=anesthesia-for-craniotomy#H8564106\" class=\"medical medical_review\">&quot;Anesthesia for craniotomy&quot;, section on 'Induction of anesthesia'</a> and <a href=\"topic.htm?path=anesthesia-for-patients-with-acute-traumatic-brain-injury#H128065263\" class=\"medical medical_review\">&quot;Anesthesia for patients with acute traumatic brain injury&quot;, section on 'Choice of anesthetic agents'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Eye injury</strong> &ndash; (See <a href=\"topic.htm?path=anesthesia-for-emergent-eye-surgery#H190962211\" class=\"medical medical_review\">&quot;Anesthesia for emergent eye surgery&quot;, section on 'Choice of induction and adjuvant agents'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Potentially difficult airway</strong> &ndash; (See <a href=\"topic.htm?path=management-of-the-difficult-airway-for-general-anesthesia-in-adults#H340131\" class=\"medical medical_review\">&quot;Management of the difficult airway for general anesthesia in adults&quot;, section on 'Induction of anesthesia'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Aspiration risk</strong> &ndash; (See <a href=\"topic.htm?path=rapid-sequence-induction-and-intubation-rsii-for-anesthesia#H1078269059\" class=\"medical medical_review\">&quot;Rapid sequence induction and intubation (RSII) for anesthesia&quot;, section on 'Induction agents'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Heart disease</strong> &ndash; (See <a href=\"topic.htm?path=anesthesia-for-noncardiac-surgery-in-patients-with-ischemic-heart-disease#H2200606372\" class=\"medical medical_review\">&quot;Anesthesia for noncardiac surgery in patients with ischemic heart disease&quot;, section on 'Induction'</a> and <a href=\"topic.htm?path=anesthesia-for-noncardiac-surgery-in-patients-with-heart-failure#H778087600\" class=\"medical medical_review\">&quot;Anesthesia for noncardiac surgery in patients with heart failure&quot;, section on 'Induction'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>End stage renal disease</strong> &ndash; (See <a href=\"topic.htm?path=anesthesia-for-the-patient-on-dialysis#H3801553334\" class=\"medical medical_review\">&quot;Anesthesia for the patient on dialysis&quot;, section on 'Induction'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Others </strong>&ndash; See other topic reviews for recommended modifications for the induction technique in specific conditions and for specific procedures.</p><p/><p/><p class=\"headingAnchor\" id=\"H888004209\"><span class=\"h1\">SUMMARY AND RECOMMENDATIONS</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The goals for induction of general anesthesia are to induce a state of amnesia, analgesia, akinesia, and autonomic block while maintaining hemodynamic stability and ventilation. (See <a href=\"#H2326701429\" class=\"local\">'Introduction'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Anesthetic agents demonstrate a dose-response effect, with progressively higher doses providing progressively deeper levels of sedation and anesthesia (<a href=\"image.htm?imageKey=ANEST%2F107796\" class=\"graphic graphic_table graphicRef107796 \">table 1</a>). (See <a href=\"#H2107374177\" class=\"local\">'Continuum of sedation during anesthetic induction'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Planning for induction includes the anesthesia machine checkout procedure, preparation for advanced airway management, preparation of routinely administered drugs, and confirmation of availability of drugs for treatment of common complications and emergencies. (See <a href=\"#H1788937456\" class=\"local\">'Preparation before patient arrival'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Prior to induction, the adult patient should be connected to the standard American Society of Anesthesiologists (ASA) monitors and should have adequate intravenous (IV) access. An appropriate preprocedure checklist should be completed. (See <a href=\"#H2417514694\" class=\"local\">'Preparation after patient arrival'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The patient is positioned for optimal airway management (eg, &quot;sniffing&quot; position), with the head up (ie, reverse Trendelenburg or <span class=\"nowrap\">semi-sitting/&quot;semi-Fowler&quot;</span> position). Preoxygenation is accomplished using 100 percent oxygen (O<sub>2</sub>). (See <a href=\"#H2134519527\" class=\"local\">'Preparation immediately before induction'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Most adult patients prefer IV induction of anesthesia with a sedative-hypnotic agent (eg, <a href=\"topic.htm?path=propofol-drug-information\" class=\"drug drug_general\">propofol</a>, <a href=\"topic.htm?path=etomidate-drug-information\" class=\"drug drug_general\">etomidate</a>, <a href=\"topic.htm?path=ketamine-drug-information\" class=\"drug drug_general\">ketamine</a>) (<a href=\"image.htm?imageKey=ANEST%2F102350\" class=\"graphic graphic_table graphicRef102350 \">table 5</a>) because they dislike the unpleasant odor of a volatile inhalation anesthetic agent. Also, nausea and vomiting are less likely with some IV agents (eg, propofol). One or more adjuvant agents (eg, an opioid or <a href=\"topic.htm?path=lidocaine-drug-information\" class=\"drug drug_general\">lidocaine</a>) are typically administered during induction to minimize the pain of injection of the anesthetic induction agent, blunt the reflex airway and sympathetic stress responses to laryngoscopy and endotracheal intubation, and supplement the anesthetic effects of the induction agent (<a href=\"image.htm?imageKey=ANEST%2F106541\" class=\"graphic graphic_table graphicRef106541 \">table 6</a>). (See <a href=\"#H295889468\" class=\"local\">'Selection of induction technique'</a> above and <a href=\"#H295889145\" class=\"local\">'Intravenous anesthetic induction'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Inhalation induction is often preferred by children because of their fear of needles. In adults, inhalation induction may be preferred when spontaneous breathing is desirable during induction. Inhalation induction of anesthesia requires a high concentration of a volatile anesthetic agent, with or without <a href=\"topic.htm?path=nitrous-oxide-drug-information\" class=\"drug drug_general\">nitrous oxide</a> (N<sub>2</sub>O). Development of non-pungent, nonirritant volatile anesthetics that have rapid onset, particularly <a href=\"topic.htm?path=sevoflurane-drug-information\" class=\"drug drug_general\">sevoflurane</a>, has made inhalation induction of anesthesia via facemask a more pleasant and viable option compared with older inhalation agents (<a href=\"image.htm?imageKey=ANEST%2F113972\" class=\"graphic graphic_table graphicRef113972 \">table 8</a>). (See <a href=\"#H295889239\" class=\"local\">'Inhalation anesthetic induction'</a> above.) </p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>A neuromuscular blocking agent (NMBA) is administered to facilitate laryngoscopy when endotracheal intubation is planned (<a href=\"image.htm?imageKey=ANEST%2F114271\" class=\"graphic graphic_table graphicRef114271 \">table 7</a>). Unless specifically contraindicated, <a href=\"topic.htm?path=succinylcholine-suxamethonium-drug-information\" class=\"drug drug_general\">succinylcholine</a> (SCh) is selected for patients requiring rapid sequence induction and intubation (RSII) and in those with a potentially difficult airway. For other patients, we typically select a nondepolarizing NMBA (eg, <a href=\"topic.htm?path=rocuronium-drug-information\" class=\"drug drug_general\">rocuronium</a>, <a href=\"topic.htm?path=vecuronium-drug-information\" class=\"drug drug_general\">vecuronium</a>, <a href=\"topic.htm?path=cisatracurium-drug-information\" class=\"drug drug_general\">cisatracurium</a>) for intubation, particularly if muscle relaxation is desired for longer than a few minutes. (See <a href=\"#H2800567302\" class=\"local\">'Neuromuscular blocking agents'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Vasopressor agents are administered, if necessary, to treat hypotension during induction of general anesthesia. (See <a href=\"#H2986651352\" class=\"local\">'Vasopressor agents'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Patient-specific and procedure-specific considerations that affect induction technique <span class=\"nowrap\">and/or</span> selection of agents include hemodynamic instability, aspiration risk, potentially difficult airway, and specific disease states. (See <a href=\"#H3152925089\" class=\"local\">'Patient-specific and procedure-specific considerations'</a> above.)</p><p/></div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\"><li class=\"breakAll\">https://www.asahq.org/For-Members/Clinical-Information/2008-ASA-Recommendations-for-PreAnesthesia-Checkout.aspx.</li><li class=\"breakAll\">American Society of Anesthesiologists. Standards for Basic Anesthetic Monitoring. www.asahq.org/Search.aspx?q=standards+basic+anesthetic+monitoring (Accessed on March 29, 2016).</li><li><a href=\"https://www.uptodate.com/contents/general-anesthesia-induction/abstract/3\" class=\"nounderline abstract_t\">Kobayashi M, Ayuse T, Hoshino Y, et al. Effect of head elevation on passive upper airway collapsibility in normal subjects during propofol anesthesia. Anesthesiology 2011; 115:273.</a></li><li><a href=\"https://www.uptodate.com/contents/general-anesthesia-induction/abstract/4\" class=\"nounderline abstract_t\">Tanoubi I, Drolet P, Donati F. Optimizing preoxygenation in adults. Can J Anaesth 2009; 56:449.</a></li><li><a href=\"https://www.uptodate.com/contents/general-anesthesia-induction/abstract/5\" class=\"nounderline abstract_t\">Nimmagadda U, Salem MR, Crystal GJ. Preoxygenation: Physiologic Basis, Benefits, and Potential Risks. Anesth Analg 2017; 124:507.</a></li><li><a href=\"https://www.uptodate.com/contents/general-anesthesia-induction/abstract/6\" class=\"nounderline abstract_t\">Smith C, McEwan AI, Jhaveri R, et al. The interaction of fentanyl on the Cp50 of propofol for loss of consciousness and skin incision. Anesthesiology 1994; 81:820.</a></li><li><a href=\"https://www.uptodate.com/contents/general-anesthesia-induction/abstract/7\" class=\"nounderline abstract_t\">Kazama T, Ikeda K, Morita K. The pharmacodynamic interaction between propofol and fentanyl with respect to the suppression of somatic or hemodynamic responses to skin incision, peritoneum incision, and abdominal wall retraction. Anesthesiology 1998; 89:894.</a></li><li><a href=\"https://www.uptodate.com/contents/general-anesthesia-induction/abstract/8\" class=\"nounderline abstract_t\">Short TG, Plummer JL, Chui PT. Hypnotic and anaesthetic interactions between midazolam, propofol and alfentanil. Br J Anaesth 1992; 69:162.</a></li><li><a href=\"https://www.uptodate.com/contents/general-anesthesia-induction/abstract/9\" class=\"nounderline abstract_t\">Kazama T, Ikeda K, Morita K. Reduction by fentanyl of the Cp50 values of propofol and hemodynamic responses to various noxious stimuli. Anesthesiology 1997; 87:213.</a></li><li><a href=\"https://www.uptodate.com/contents/general-anesthesia-induction/abstract/10\" class=\"nounderline abstract_t\">Van Aken H, Meinshausen E, Prien T, et al. The influence of fentanyl and tracheal intubation on the hemodynamic effects of anesthesia induction with propofol/N2O in humans. Anesthesiology 1988; 68:157.</a></li><li><a href=\"https://www.uptodate.com/contents/general-anesthesia-induction/abstract/11\" class=\"nounderline abstract_t\">Maurice-Szamburski A, Auquier P, Viarre-Oreal V, et al. Effect of sedative premedication on patient experience after general anesthesia: a randomized clinical trial. JAMA 2015; 313:916.</a></li><li><a href=\"https://www.uptodate.com/contents/general-anesthesia-induction/abstract/12\" class=\"nounderline abstract_t\">Feldheiser A, Aziz O, Baldini G, et al. Enhanced Recovery After Surgery (ERAS) for gastrointestinal surgery, part 2: consensus statement for anaesthesia practice. Acta Anaesthesiol Scand 2016; 60:289.</a></li><li><a href=\"https://www.uptodate.com/contents/general-anesthesia-induction/abstract/13\" class=\"nounderline abstract_t\">Aouad MT, Sayyid SS, Zalaket MI, Baraka AS. Intravenous lidocaine as adjuvant to sevoflurane anesthesia for endotracheal intubation in children. Anesth Analg 2003; 96:1325.</a></li><li><a href=\"https://www.uptodate.com/contents/general-anesthesia-induction/abstract/14\" class=\"nounderline abstract_t\">Warner LO, Balch DR, Davidson PJ. Is intravenous lidocaine an effective adjuvant for endotracheal intubation in children undergoing induction of anesthesia with halothane-nitrous oxide? J Clin Anesth 1997; 9:270.</a></li><li><a href=\"https://www.uptodate.com/contents/general-anesthesia-induction/abstract/15\" class=\"nounderline abstract_t\">Davidson JA, Gillespie JA. Tracheal intubation after induction of anaesthesia with propofol, alfentanil and i.v. lignocaine. Br J Anaesth 1993; 70:163.</a></li><li><a href=\"https://www.uptodate.com/contents/general-anesthesia-induction/abstract/16\" class=\"nounderline abstract_t\">STEINHAUS JE, GASKIN L. A study of intravenous lidocaine as a suppressant of cough reflex. Anesthesiology 1963; 24:285.</a></li><li><a href=\"https://www.uptodate.com/contents/general-anesthesia-induction/abstract/17\" class=\"nounderline abstract_t\">Pandey CK, Raza M, Ranjan R, et al. Intravenous lidocaine 0.5 mg.kg-1 effectively suppresses fentanyl-induced cough. Can J Anaesth 2005; 52:172.</a></li><li><a href=\"https://www.uptodate.com/contents/general-anesthesia-induction/abstract/18\" class=\"nounderline abstract_t\">Nishino T, Hiraga K, Sugimori K. Effects of i.v. lignocaine on airway reflexes elicited by irritation of the tracheal mucosa in humans anaesthetized with enflurane. Br J Anaesth 1990; 64:682.</a></li><li><a href=\"https://www.uptodate.com/contents/general-anesthesia-induction/abstract/19\" class=\"nounderline abstract_t\">Lin CS, Sun WZ, Chan WH, et al. Intravenous lidocaine and ephedrine, but not propofol, suppress fentanyl-induced cough. Can J Anaesth 2004; 51:654.</a></li><li><a href=\"https://www.uptodate.com/contents/general-anesthesia-induction/abstract/20\" class=\"nounderline abstract_t\">Maslow AD, Regan MM, Israel E, et al. Inhaled albuterol, but not intravenous lidocaine, protects against intubation-induced bronchoconstriction in asthma. Anesthesiology 2000; 93:1198.</a></li><li><a href=\"https://www.uptodate.com/contents/general-anesthesia-induction/abstract/21\" class=\"nounderline abstract_t\">Pandey CK, Raza M, Ranjan R, et al. Intravenous lidocaine suppresses fentanyl-induced coughing: a double-blind, prospective, randomized placebo-controlled study. Anesth Analg 2004; 99:1696.</a></li><li><a href=\"https://www.uptodate.com/contents/general-anesthesia-induction/abstract/22\" class=\"nounderline abstract_t\">Yukioka H, Hayashi M, Terai T, Fujimori M. Intravenous lidocaine as a suppressant of coughing during tracheal intubation in elderly patients. Anesth Analg 1993; 77:309.</a></li><li><a href=\"https://www.uptodate.com/contents/general-anesthesia-induction/abstract/23\" class=\"nounderline abstract_t\">Jakobsen CJ, Ahlburg P, Holdg&aring;rd HO, et al. Comparison of intravenous and topical lidocaine as a suppressant of coughing after bronchoscopy during general anesthesia. Acta Anaesthesiol Scand 1991; 35:238.</a></li><li><a href=\"https://www.uptodate.com/contents/general-anesthesia-induction/abstract/24\" class=\"nounderline abstract_t\">Adamzik M, Groeben H, Farahani R, et al. Intravenous lidocaine after tracheal intubation mitigates bronchoconstriction in patients with asthma. Anesth Analg 2007; 104:168.</a></li><li><a href=\"https://www.uptodate.com/contents/general-anesthesia-induction/abstract/25\" class=\"nounderline abstract_t\">Chang HY, Togias A, Brown RH. The effects of systemic lidocaine on airway tone and pulmonary function in asthmatic subjects. Anesth Analg 2007; 104:1109.</a></li><li><a href=\"https://www.uptodate.com/contents/general-anesthesia-induction/abstract/26\" class=\"nounderline abstract_t\">Senturk M, Pembeci K, Menda F, et al. Effects of intramuscular administration of lidocaine or bupivacaine on induction and maintenance doses of propofol evaluated by bispectral index. Br J Anaesth 2002; 89:849.</a></li><li><a href=\"https://www.uptodate.com/contents/general-anesthesia-induction/abstract/27\" class=\"nounderline abstract_t\">Euasobhon P, Dej-Arkom S, Siriussawakul A, et al. Lidocaine for reducing propofol-induced pain on induction of anaesthesia in adults. Cochrane Database Syst Rev 2016; 2:CD007874.</a></li><li><a href=\"https://www.uptodate.com/contents/general-anesthesia-induction/abstract/28\" class=\"nounderline abstract_t\">Picard P, Tram&egrave;r MR. Prevention of pain on injection with propofol: a quantitative systematic review. Anesth Analg 2000; 90:963.</a></li><li><a href=\"https://www.uptodate.com/contents/general-anesthesia-induction/abstract/29\" class=\"nounderline abstract_t\">El-Radaideh KM. [Effect of pretreatment with lidocaine, intravenous paracetamol and lidocaine-fentanyl on propofol injection pain. Comparative study. Rev Bras Anestesiol 2007; 57:32.</a></li><li><a href=\"https://www.uptodate.com/contents/general-anesthesia-induction/abstract/30\" class=\"nounderline abstract_t\">Prabhakar H, Singh GP, Ali Z, et al. Pharmacological and non-pharmacological interventions for reducing rocuronium bromide induced pain on injection in children and adults. Cochrane Database Syst Rev 2016; 2:CD009346.</a></li><li><a href=\"https://www.uptodate.com/contents/general-anesthesia-induction/abstract/31\" class=\"nounderline abstract_t\">Aouad MT, Siddik-Sayyid SM, Al-Alami AA, Baraka AS. Multimodal analgesia to prevent propofol-induced pain: pretreatment with remifentanil and lidocaine versus remifentanil or lidocaine alone. Anesth Analg 2007; 104:1540.</a></li><li><a href=\"https://www.uptodate.com/contents/general-anesthesia-induction/abstract/32\" class=\"nounderline abstract_t\">Rahman Al-Refai A, Al-Mujadi H, Petrova Ivanova M, et al. Prevention of pain on injection of propofol: a comparison of remifentanil with alfentanil in children. Minerva Anestesiol 2007; 73:219.</a></li><li><a href=\"https://www.uptodate.com/contents/general-anesthesia-induction/abstract/33\" class=\"nounderline abstract_t\">Sigston PE, Jenkins AM, Jackson EA, et al. Rapid inhalation induction in children: 8% sevoflurane compared with 5% halothane. Br J Anaesth 1997; 78:362.</a></li><li><a href=\"https://www.uptodate.com/contents/general-anesthesia-induction/abstract/34\" class=\"nounderline abstract_t\">Thwaites A, Edmends S, Smith I. Inhalation induction with sevoflurane: a double-blind comparison with propofol. Br J Anaesth 1997; 78:356.</a></li><li><a href=\"https://www.uptodate.com/contents/general-anesthesia-induction/abstract/35\" class=\"nounderline abstract_t\">Joshi GP. Inhalational techniques in ambulatory anesthesia. Anesthesiol Clin North America 2003; 21:263.</a></li><li><a href=\"https://www.uptodate.com/contents/general-anesthesia-induction/abstract/36\" class=\"nounderline abstract_t\">Suzuki KS, Oohata M, Mori N. Multiple-deep-breath inhalation induction with 5% sevoflurane and 67% nitrous oxide: comparison with intravenous injection of propofol. J Anesth 2002; 16:97.</a></li><li><a href=\"https://www.uptodate.com/contents/general-anesthesia-induction/abstract/37\" class=\"nounderline abstract_t\">Lejus C, Bazin V, Fernandez M, et al. Inhalation induction using sevoflurane in children: the single-breath vital capacity technique compared to the tidal volume technique*. Anaesthesia 2006; 61:535.</a></li><li><a href=\"https://www.uptodate.com/contents/general-anesthesia-induction/abstract/38\" class=\"nounderline abstract_t\">Joo HS, Perks WJ. Sevoflurane versus propofol for anesthetic induction: a meta-analysis. Anesth Analg 2000; 91:213.</a></li><li><a href=\"https://www.uptodate.com/contents/general-anesthesia-induction/abstract/39\" class=\"nounderline abstract_t\">Boonmak P, Boonmak S, Pattanittum P. High initial concentration versus low initial concentration sevoflurane for inhalational induction of anaesthesia. Cochrane Database Syst Rev 2016; :CD006837.</a></li><li><a href=\"https://www.uptodate.com/contents/general-anesthesia-induction/abstract/40\" class=\"nounderline abstract_t\">White PF, Tang J, Wender RH, et al. Desflurane versus sevoflurane for maintenance of outpatient anesthesia: the effect on early versus late recovery and perioperative coughing. Anesth Analg 2009; 109:387.</a></li><li><a href=\"https://www.uptodate.com/contents/general-anesthesia-induction/abstract/41\" class=\"nounderline abstract_t\">Mostafa SM, Atherton AM. Sevoflurane for difficult tracheal intubation. Br J Anaesth 1997; 79:392.</a></li><li class=\"breakAll\">Thomas Ebert and Larry Lindenbaum. Inhaled Anesthetics. In: Clinical Anesthesia, Seventh, Paul G. Barash (Ed), Lippincott Williams Wilkins, Philadelphia 2013. p.447-477.</li><li><a href=\"https://www.uptodate.com/contents/general-anesthesia-induction/abstract/43\" class=\"nounderline abstract_t\">de Oliveira GS Jr, Girao W, Fitzgerald PC, McCarthy RJ. The effect of sevoflurane versus desflurane on the incidence of upper respiratory morbidity in patients undergoing general anesthesia with a Laryngeal Mask Airway: a meta-analysis of randomized controlled trials. J Clin Anesth 2013; 25:452.</a></li><li><a href=\"https://www.uptodate.com/contents/general-anesthesia-induction/abstract/44\" class=\"nounderline abstract_t\">Torri G. Inhalation anesthetics: a review. Minerva Anestesiol 2010; 76:215.</a></li><li><a href=\"https://www.uptodate.com/contents/general-anesthesia-induction/abstract/45\" class=\"nounderline abstract_t\">Sun R, Jia WQ, Zhang P, et al. Nitrous oxide-based techniques versus nitrous oxide-free techniques for general anaesthesia. Cochrane Database Syst Rev 2015; :CD008984.</a></li><li><a href=\"https://www.uptodate.com/contents/general-anesthesia-induction/abstract/46\" class=\"nounderline abstract_t\">Myles PS, Chan MT, Kasza J, et al. Severe Nausea and Vomiting in the Evaluation of Nitrous Oxide in the Gas Mixture for Anesthesia II Trial. Anesthesiology 2016; 124:1032.</a></li><li><a href=\"https://www.uptodate.com/contents/general-anesthesia-induction/abstract/47\" class=\"nounderline abstract_t\">de Boer HD, Driessen JJ, Marcus MA, et al. Reversal of rocuronium-induced (1.2 mg/kg) profound neuromuscular block by sugammadex: a multicenter, dose-finding and safety study. Anesthesiology 2007; 107:239.</a></li><li><a href=\"https://www.uptodate.com/contents/general-anesthesia-induction/abstract/48\" class=\"nounderline abstract_t\">P&uuml;hringer FK, Rex C, Sielenk&auml;mper AW, et al. Reversal of profound, high-dose rocuronium-induced neuromuscular blockade by sugammadex at two different time points: an international, multicenter, randomized, dose-finding, safety assessor-blinded, phase II trial. Anesthesiology 2008; 109:188.</a></li></ol></div><div id=\"topicVersionRevision\">Topic 94135 Version 30.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul id=\"innerOutline\"><li class=\"sr-button\"><a href=\"#H888004209\"><span>SUMMARY &amp; RECOMMENDATIONS</span></a></li><li><a href=\"#H2326701429\" id=\"outline-link-H2326701429\">INTRODUCTION</a></li><li><a href=\"#H2107374177\" id=\"outline-link-H2107374177\">CONTINUUM OF SEDATION DURING ANESTHETIC INDUCTION</a></li><li><a href=\"#H254392428\" id=\"outline-link-H254392428\">PREPARATION FOR ANESTHETIC INDUCTION</a><ul><li><a href=\"#H1788937456\" id=\"outline-link-H1788937456\">Preparation before patient arrival</a></li><li><a href=\"#H2417514694\" id=\"outline-link-H2417514694\">Preparation after patient arrival</a></li><li><a href=\"#H2134519527\" id=\"outline-link-H2134519527\">Preparation immediately before induction</a></li></ul></li><li><a href=\"#H295889468\" id=\"outline-link-H295889468\">SELECTION OF INDUCTION TECHNIQUE</a></li><li><a href=\"#H295889145\" id=\"outline-link-H295889145\">INTRAVENOUS ANESTHETIC INDUCTION</a><ul><li><a href=\"#H3372096285\" id=\"outline-link-H3372096285\">Induction with endotracheal intubation</a></li><li><a href=\"#H1691645889\" id=\"outline-link-H1691645889\">Induction with supraglottic airway placement</a></li></ul></li><li><a href=\"#H295889239\" id=\"outline-link-H295889239\">INHALATION ANESTHETIC INDUCTION</a><ul><li><a href=\"#H1232736222\" id=\"outline-link-H1232736222\">Volatile inhalation agents</a></li><li><a href=\"#H163527534\" id=\"outline-link-H163527534\">Nitrous oxide gas</a></li></ul></li><li><a href=\"#H2800567302\" id=\"outline-link-H2800567302\">NEUROMUSCULAR BLOCKING AGENTS</a></li><li><a href=\"#H2986651352\" id=\"outline-link-H2986651352\">VASOPRESSOR AGENTS</a></li><li><a href=\"#H3152925089\" id=\"outline-link-H3152925089\">PATIENT-SPECIFIC AND PROCEDURE-SPECIFIC CONSIDERATIONS</a></li><li><a href=\"#H888004209\" id=\"outline-link-H888004209\">SUMMARY AND RECOMMENDATIONS</a></li><li><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"ANEST/94135|TAB\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"TABLES\">TABLES</a></div><ul><li><a href=\"image.htm?imageKey=ANEST/107796\" class=\"graphic graphic_table\">- Stages of anesthetic depth</a></li><li><a href=\"image.htm?imageKey=ANEST/101563\" class=\"graphic graphic_table\">- Summary of anesthesia machine checkout recommendations</a></li><li><a href=\"image.htm?imageKey=ANEST/110080\" class=\"graphic graphic_table\">- Basic monitoring during anesthesia</a></li><li><a href=\"image.htm?imageKey=ANEST/52392\" class=\"graphic graphic_table\">- World Health Organization surgical safety checklist</a></li><li><a href=\"image.htm?imageKey=ANEST/102350\" class=\"graphic graphic_table\">- Intravenous anesthetic induction agents</a></li><li><a href=\"image.htm?imageKey=ANEST/106541\" class=\"graphic graphic_table\">- IV adjuvant agents for induction of general anesthesia</a></li><li><a href=\"image.htm?imageKey=ANEST/114271\" class=\"graphic graphic_table\">- Properties of NMBAs</a></li><li><a href=\"image.htm?imageKey=ANEST/113972\" class=\"graphic graphic_table\">- Inhalation anesthetic agents</a></li><li><a href=\"image.htm?imageKey=ANEST/96387\" class=\"graphic graphic_table\">- Vasoactive infusions used in the operating room: Adult dosing</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li class=\"plainItem\"><a href=\"topic.htm?path=airway-management-for-induction-of-general-anesthesia\" class=\"medical medical_review\">Airway management for induction of general anesthesia</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=anesthesia-for-craniotomy\" class=\"medical medical_review\">Anesthesia for craniotomy</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=anesthesia-for-emergent-eye-surgery\" class=\"medical medical_review\">Anesthesia for emergent eye surgery</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=anesthesia-for-noncardiac-surgery-in-patients-with-heart-failure\" class=\"medical medical_review\">Anesthesia for noncardiac surgery in patients with heart failure</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=anesthesia-for-noncardiac-surgery-in-patients-with-ischemic-heart-disease\" class=\"medical medical_review\">Anesthesia for noncardiac surgery in patients with ischemic heart disease</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=anesthesia-for-patients-with-acute-traumatic-brain-injury\" class=\"medical medical_review\">Anesthesia for patients with acute traumatic brain injury</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=anesthesia-for-the-older-adult\" class=\"medical medical_review\">Anesthesia for the older adult</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=anesthesia-for-the-patient-on-dialysis\" class=\"medical medical_review\">Anesthesia for the patient on dialysis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=anesthesia-machines-prevention-diagnosis-and-management-of-malfunctions\" class=\"medical medical_review\">Anesthesia machines: Prevention, diagnosis, and management of malfunctions</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-use-of-neuromuscular-blocking-agents-in-anesthesia\" class=\"medical medical_review\">Clinical use of neuromuscular blocking agents in anesthesia</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=evaluation-of-cardiac-risk-prior-to-noncardiac-surgery\" class=\"medical medical_review\">Evaluation of cardiac risk prior to noncardiac surgery</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=evaluation-of-preoperative-pulmonary-risk\" class=\"medical medical_review\">Evaluation of preoperative pulmonary risk</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=general-anesthesia-intravenous-induction-agents\" class=\"medical medical_review\">General anesthesia: Intravenous induction agents</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=inhalation-anesthetic-agents-clinical-effects-and-uses\" class=\"medical medical_review\">Inhalation anesthetic agents: Clinical effects and uses</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=inhalation-anesthetic-agents-properties-and-delivery\" class=\"medical medical_review\">Inhalation anesthetic agents: Properties and delivery</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=intraoperative-management-of-shock-in-adults\" class=\"medical medical_review\">Intraoperative management of shock in adults</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=management-of-the-difficult-airway-for-general-anesthesia-in-adults\" class=\"medical medical_review\">Management of the difficult airway for general anesthesia in adults</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=monitoring-during-anesthesia\" class=\"medical medical_review\">Monitoring during anesthesia</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=perioperative-medication-management\" class=\"medical medical_review\">Perioperative medication management</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=peripheral-venous-access-in-adults\" class=\"medical medical_review\">Peripheral venous access in adults</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=preanesthesia-evaluation-for-noncardiac-surgery\" class=\"medical medical_review\">Preanesthesia evaluation for noncardiac surgery</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=preoperative-fasting-guidelines\" class=\"medical medical_review\">Preoperative fasting guidelines</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=preoperative-medical-evaluation-of-the-adult-healthy-patient\" class=\"medical medical_review\">Preoperative medical evaluation of the adult healthy patient</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=rapid-sequence-induction-and-intubation-rsii-for-anesthesia\" class=\"medical medical_review\">Rapid sequence induction and intubation (RSII) for anesthesia</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=supraglottic-devices-including-laryngeal-mask-airways-for-airway-management-for-anesthesia-in-adults\" class=\"medical medical_review\">Supraglottic devices (including laryngeal mask airways) for airway management for anesthesia in adults</a></li></ul></div></div>","javascript":null}